Table 2 Bivariate and Multivariable Associations between IPV during pregnancy, baseline covariates and symptoms of PPD at follow-up
| Â | Model 1a | Model 2b | ||
|---|---|---|---|---|
| Â | RR (95% CI) | p-value | RR (95% CI) | p-value |
IPV during pregnancy | 1.50 (0.97, 2.31) | 0.07 | 1.62 (1.06, 2.49) | 0.03 |
Age (in years) | 1.06 (0.89, 1.27) | 0.51 | 0.99 (0.82, 1.20) | 0.95 |
SES | Â | Â | Â | Â |
 Low | Ref. |  | Ref. |  |
 Middle | 1.12 (0.68, 1.86) | 0.65 | 1.04 (0.66, 1.64) | 0.86 |
 High | 1.16 (0.64, 2.09) | 0.63 | 1.13 (0.60, 2.14) | 0.71 |
HIV-positive | 1.31 (0.83, 2.08) | 0.24 | 1.33 (0.82, 2.18) | 0.25 |
STI diagnosis | 0.77 (0.39, 1.51) | 0.45 | 1.00 (0.54, 1.85) | 0.99 |
Perceived Social Support Score | 0.92 (0.62, 1.37) | 0.69 | 0.93 (0.60, 1.44) | 0.75 |
Two children at time of delivery | 1.08 (0.56, 2.10) | 0.82 | 0.96 (0.50, 1.83) | 0.9 |
Symptoms of PPD within 4Â weeks postpartum | 2.23 (1.18, 4.22) | 0.01 | 2.49 (1.31, 4.72) | 0.01 |
Attended at least 1 intervention session | 0.89 (0.56, 1.40) | 0.61 | 0.82 (0.49, 1.38) | 0.46 |
Timing between baseline and follow-up (in weeks) | 0.98 (0.82, 1.15) | 0.77 | 0.91 (0.78, 1.07) | 0.27 |